Goldman Sachs Maintains Neutral on Baxter International, Raises Price Target to $21

Baxter International Inc.

Baxter International Inc.

BAX

0.00

Goldman Sachs analyst David Roman maintains Baxter International (NYSE: BAX) with a Neutral and raises the price target from $19 to $21.